Veeva CEO gives post-IPO interview

Veeva Systems ($VEEV) CEO Peter Gassner spoke to Forbes about the company and its plans to expand its products. Gassner picked out tools to help sales reps track drug samples and visits to doctors as areas of focus. Veeva is also working to manage the clinical trial workflow. Interview

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.